CME vs NDAQ

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Jan 31, 2026

CME

64.8
AI Score
VS
CME Wins

NDAQ

59.2
AI Score

Investment Advisor Scores

CME

65score
Recommendation
BUY

NDAQ

59score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CME NDAQ Winner
Forward P/E 24.1546 26.178 CME
PEG Ratio 5.3147 1.9262 NDAQ
Revenue Growth -3.0% 2.9% NDAQ
Earnings Growth -0.4% 37.7% NDAQ
Tradestie Score 64.8/100 59.2/100 CME
Profit Margin 59.0% 19.9% CME
Beta 1.00 1.00 Tie
AI Recommendation BUY HOLD CME

Frequently Asked Questions

Based on our detailed analysis, CME is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.